OptiBio is a South Korean healthcare company focused on fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates Foundation for its unique and dedicated approach to immunoassay. OptiBio's competitive advantage stems from its str...